Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?

Raoul Orvieto; Jenya Kruchkovich; Efraim Zohav; Jacob Rabinson; Eyal Y Anteby; Simion Meltcer

doi:10.1016/j.fertnstert.2007.01.064

Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?

Fertil Steril. 2007 Dec;88(6):1685-6. doi: 10.1016/j.fertnstert.2007.01.064. Epub 2007 May 10.

Authors

Raoul Orvieto¹, Jenya Kruchkovich, Efraim Zohav, Jacob Rabinson, Eyal Y Anteby, Simion Meltcer

Affiliation

¹ Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel. raoulo@barzi.health.gov.il

PMID: 17493622
DOI: 10.1016/j.fertnstert.2007.01.064

Abstract

In a study on the influence of methotrexate (MTX) treatment on ovarian stimulation characteristics during the subsequent IVF cycle, 14 patients admitted to our department with the diagnosis of ectopic pregnancy and successfully treated with MTX were evaluated. No differences were observed in ovarian stimulation characteristics between the IVF cycle that had resulted in the ectopic pregnancy and the IVF cycle that followed MTX treatment. Treating ectopic pregnancy with MTX has no influence on patients' performance in the following IVF cycle.

Publication types

Evaluation Study

MeSH terms

Abortifacient Agents, Nonsteroidal / adverse effects
Abortifacient Agents, Nonsteroidal / therapeutic use
Adult
Embryo Transfer*
Female
Fertilization in Vitro / drug effects*
Humans
Methotrexate / adverse effects*
Methotrexate / therapeutic use*
Pregnancy
Pregnancy, Ectopic / drug therapy*
Retrospective Studies
Treatment Outcome

Substances

Abortifacient Agents, Nonsteroidal
Methotrexate